 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 January 1998 | Volume 128 Issue 1 | Pages 15-20
Background: The factor V Leiden mutation is a genetic defect associated with an increased incidence of venous thromboembolism. When the incidence of venous thromboembolism in relatives of patients known to have the mutation outweighs the disadvantages of prophylactic strategies, family screening may be necessary.
Objective: To determine the incidence of venous thromboembolism in first-degree relatives of symptomatic carriers of the factor V Leiden mutation.
Design: Retrospective blinded study.
Setting: University hospitals.
Participants: 437 first-degree relatives of 112 heterozygous propositi and 30 relatives of 6 homozygous propositi.
Measurements: Before DNA testing, information on previous venous thromboembolism and concomitant risk factors was obtained. Relatives with and without the FV: Q506 mutation were compared.
Results: The annual incidence of thromboembolism in relatives of heterozygous propositi was 0.45% (95% CI, 0.28% to 0.61%) in those with the mutation and 0.10% (CI, 0.02% to 0.19%) in those without the mutation (relative risk, 4.2 [CI, 1.8 to 9.9]). Among carriers, the incidence increased from 0.25% (CI, 0.12% to 0.49%) in the 15- to 30-year-old age group to 1.1% (CI, 0.24% to 3.33%) in persons older than 60 years of age. Half of the episodes of venous thromboembolism occurred spontaneously, 20% were related to surgery, and 30% were associated with pregnancy or use of oral contraceptives.
Conclusions: The observed low annual risk for venous thromboembolism in persons carrying the factor V Leiden mutation does not seem to outweigh the risks for bleeding associated with coumarin prophylaxis or justify discouragement of the use of oral contraceptives. A general policy of screening the families of all patients with the factor V Leiden mutation does not seem to be indicated. The observations in this moderate-size, retrospective study need to be confirmed by prospective follow-up studies.
Author and Article Information
From the Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; University Hospital Groningen, Groningen, the Netherlands; and University Hospital Maastricht, Maastricht, the Netherlands.
ARTICLE
The Incidence of Venous Thromboembolism in Family Members of Patients with Factor V Leiden Mutation and Venous Thrombosis
Acknowledgment: The authors thank Professor Jan Wouter ten Cate for his helpful comments.
Grant Support: By grant 28-2783 from the Praeventiefonds. Dr. Buller is an Established Investigator of the Netherlands Heart Association.
Requests for Reprints: Saskia Middeldrop, MD, Center for Haemostasis, Thrombosis, Atherosclerosis and Inflammation Research, F-4, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.
Current Author Addresses: Drs. Middeldorp, Koopman, and Buller: Center for Haemostasis, Thrombosis, Atherosclerosis and Inflammation Research, F-4, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.
This article has been cited by other articles:
|
|
 |
|
  L Merriman and M Greaves Testing for thrombophilia: an evidence-based approach Postgrad. Med. J., November 1, 2006; 82(973): 699 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Nuttall, N. Henderson, M. Quinn, C. Blair, L. Summers, B. A. Williams, W. C. Oliver, and P. J. Santrach Excessive bleeding and transfusion in a prior cardiac surgery is associated with excessive bleeding and transfusion in the next surgery. Anesth. Analg., April 1, 2006; 102(4): 1012 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Bank, E. J. Libourel, S. Middeldorp, E. C. M. van Pampus, M. M. W. Koopman, K. Hamulyak, M. H. Prins, J. van der Meer, and H. R. Buller Prothrombin 20210A Mutation: A Mild Risk Factor for Venous Thromboembolism but Not for Arterial Thrombotic Disease and Pregnancy-Related Complications in a Family Study Arch Intern Med, September 27, 2004; 164(17): 1932 - 1937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Weitz, S. Middeldorp, W. Geerts, and J. A. Heit Thrombophilia and New Anticoagulant Drugs Hematology, January 1, 2004; 2004(1): 424 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Eckman, J. K. Erban, S. K. Singh, and G. S. Kao Screening for the Risk for Bleeding or Thrombosis Ann Intern Med, February 4, 2003; 138(3): W-15 - W-24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R Deitcher and M. P. Gomes Hypercoagulable state testing and malignancy screening following venous thromboembolic events Vascular Medicine, February 1, 2003; 8(1): 33 - 46. [Abstract] [PDF]
|
|
|
|
|
|
S. Middeldorp, H. R. Buller, and M. H. Prins Risk for Venous Thromboembolism in Carriers of the Factor V Leiden Mutation Ann Intern Med, January 7, 2003; 138(1): 76 - 77. [Full Text] [PDF]
|
|
|
|
|
|
A. I. Schafer, M. N. Levine, B. A. Konkle, and C. Kearon Thrombotic Disorders: Diagnosis and Treatment Hematology, January 1, 2003; 2003(1): 520 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tormene, P. Simioni, P. Prandoni, F. Franz, P. Zerbinati, G. Tognin, and A. Girolami The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study Blood, September 18, 2002; 100(7): 2403 - 2405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Burke, D. Atkins, M. Gwinn, A. Guttmacher, J. Haddow, J. Lau, G. Palomaki, N. Press, C. S. Richards, L. Wideroff, et al. Genetic Test Evaluation: Information Needs of Clinicians, Policy Makers, and the Public Am. J. Epidemiol., August 15, 2002; 156(4): 311 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Simioni, D. Tormene, P. Prandoni, P. Zerbinati, S. Gavasso, P. Cefalo, and A. Girolami Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study Blood, March 15, 2002; 99(6): 1938 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Middeldorp, J. R. Meinardi, M. M.W. Koopman, E. C.M. van Pampus, K. Hamulyak, J. van der Meer, M. H. Prins, and H. R. Buller A Prospective Study of Asymptomatic Carriers of the Factor V Leiden Mutation To Determine the Incidence of Venous Thromboembolism Ann Intern Med, September 4, 2001; 135(5): 322 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Bauer The Thrombophilias: Well-Defined Risk Factors with Uncertain Therapeutic Implications Ann Intern Med, September 4, 2001; 135(5): 367 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Green Genetic hypercoagulability: screening should be an informed choice Blood, July 1, 2001; 98(1): 20 - 20. [Full Text] [PDF]
|
|
|
|
|
|
P. M. Mannucci Genetic hypercoagulability: prevention suggests testing family members Blood, July 1, 2001; 98(1): 21 - 22. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Seligsohn and A. Lubetsky Genetic Susceptibility to Venous Thrombosis N. Engl. J. Med., April 19, 2001; 344(16): 1222 - 1231. [Full Text] [PDF]
|
|
|
|
|
|
B.-J. Sanson, P. Simioni, D. Tormene, M. Moia, P. W. Friederich, M. V. Huisman, P. Prandoni, A. Bura, L. Rejto, P. Wells, et al. The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study Blood, December 1, 1999; 94(11): 3702 - 3706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Meinardi, S. Middeldorp, P. J. de Kam, M. M.W. Koopman, E. C.M. van Pampus, K. Hamulyak, M. H. Prins, H. R. Buller, and J. van der Meer Increased Risk for Fetal Loss in Carriers of the Factor V Leiden Mutation Ann Intern Med, May 4, 1999; 130(9): 736 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bucciarelli, F. R. Rosendaal, A. Tripodi, P. M. Mannucci, V. De Stefano, G. Palareti, G. Finazzi, F. Baudo, and R. Quintavalla Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C Resistance : A Multicenter Collaborative Family Study Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 1026 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Simioni, P. Prandoni, and A. Girolami Low Rate of Venous Thromboembolism in Asymptomatic Relatives of Probands with Factor V Leiden Mutation Ann Intern Med, March 16, 1999; 130(6): 538 - 538. [Full Text] [PDF]
|
|
|
|
|
|
O. Salomon, D. M. Steinberg, A. Zivelin, S. Gitel, R. Dardik, N. Rosenberg, S. Berliner, A. Inbal, A. Many, A. Lubetsky, et al. Single and Combined Prothrombotic Factors in Patients With Idiopathic Venous Thromboembolism : Prevalence and Risk Assessment Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 511 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 SHOULD FAMILIES BE SCREENED FOR FACTOR V LEIDEN MUTATION? Journal Watch (General), January 16, 1998; 1998(116): 6 - 6. [Full Text]
|
|
Article
